LONDON, Sept. 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Fatty Liver Disease Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/617103/Fatty-Liver-Disease-Global-Clinical-Trials-Review-H2-2014.html
Fatty Liver Disease Global Clinical Trials Review, H2, 2014
SummaryGlobalData's clinical trial report, "Fatty Liver Disease Global Clinical Trials Review, H2, 2014" provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fatty Liver Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesTable of ContentsTable of Contents 2List of Tables 4List of Figures 5Introduction 6Fatty Liver Disease 6Report Guidance 6Clinical Trials by Region 7Clinical Trials and Average Enrollment by Country 8Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10Top Five Countries Contributing to Clinical Trials in Europe 11Top Countries Contributing to Clinical Trials in North America 12Top Countries Contributing to Clinical Trials in Middle East and Africa 13Top Countries Contributing to Clinical Trials in Central and South America 14Clinical Trials by G7 Countries: Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials 15Clinical Trials by Phase in G7 Countries 16Clinical Trials in G7 Countries by Trial Status 17Clinical Trials by E7 Countries: Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials 18Clinical Trials by Phase in E7 Countries 19Clinical Trials in E7 Countries by Trial Status 20Clinical Trials by Phase 21In Progress Trials by Phase 22Clinical Trials by Trial Status 23Clinical Trials by End Point Status 24Unaccomplished Trials of Fatty Liver Disease 25Subjects Recruited Over a Period of Time 27Clinical Trials by Sponsor Type 28Prominent Sponsors 29Top Companies Participating in Fatty Liver Disease Therapeutics Clinical Trials 30Prominent Drugs 32Latest Clinical Trials News on Fatty Liver Disease 33Jul 30, 2014: Galectin Therapeutics Issues Statement on GR-MD-02 Development Program 33Jul 25, 2014: Galectin Therapeutics to Host Webcast to Discuss Findings From Cohort 2 of Phase 1 Clinical Trial of GR-MD-02 in Fatty Liver Disease With Advanced Fibrosis 34Clinical Trial Profiles 35Clinical Trial Overview of Top Companies 35Merck & Co., Inc. 35Clinical Trial Overview of Merck & Co., Inc. 35Galmed International Ltd. 36Clinical Trial Overview of Galmed International Ltd. 36F. Hoffmann-La Roche Ltd. 37Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 37PharmaKing Co., Ltd. 38Clinical Trial Overview of PharmaKing Co., Ltd. 38Abbott Laboratories 39Clinical Trial Overview of Abbott Laboratories 39TCM Biotech International Corp 40Clinical Trial Overview of TCM Biotech International Corp 40Sanofi 41Clinical Trial Overview of Sanofi 41Phenex Pharmaceuticals AG 42Clinical Trial Overview of Phenex Pharmaceuticals AG 42GW Pharmaceuticals plc 43Clinical Trial Overview of GW Pharmaceuticals plc 43Genextra S.p.a. 44Clinical Trial Overview of Genextra S.p.a. 44Clinical Trial Overview of Top Institutes / Government 45The National Institute of Diabetes and Digestive and Kidney Diseases 45Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 45Tabriz University of Medical Sciences 46Clinical Trial Overview of Tabriz University of Medical Sciences 46Third Military Medical University 47Clinical Trial Overview of Third Military Medical University 47University of Michigan 48Clinical Trial Overview of University of Michigan 48Tehran University of Medical Sciences 49Clinical Trial Overview of Tehran University of Medical Sciences 49Washington University School of Medicine 50Clinical Trial Overview of Washington University School of Medicine 50University of California, San Diego 51Clinical Trial Overview of University of California, San Diego 51FUDAN University 52Clinical Trial Overview of FUDAN University 52Ahvaz Jundishapur University of Medical Sciences 53Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 53Bambino Gesu Hospital and Research Institute 54Clinical Trial Overview of Bambino Gesu Hospital and Research Institute 54Five Key Clinical Profiles 55Appendix 82Abbreviations 82Definitions 82Research Methodology 83Secondary Research 84About GlobalData 84Contact Us 84Disclaimer 84Source 85
List of TablesFatty Liver Disease Therapeutics, Global, Clinical Trials by Region, 2014* 7Fatty Liver Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8Fatty Liver Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9Fatty Liver Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10Fatty Liver Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11Fatty Liver Disease Therapeutics Clinical Trials, North America, Top Countries, 2014* 12Fatty Liver Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13Fatty Liver Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2014* 15Fatty Liver Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16Fatty Liver Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2014* 18Fatty Liver Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19Fatty Liver Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20Fatty Liver Disease Therapeutics, Global, Clinical Trials by Phase, 2014* 21Fatty Liver Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22Fatty Liver Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23Fatty Liver Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24Fatty Liver Disease Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25Fatty Liver Disease Therapeutics, Global, Terminated Clinical Trials, 2014* 26Fatty Liver Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27Fatty Liver Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28Fatty Liver Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29Fatty Liver Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31Fatty Liver Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 35Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Galmed International Ltd., 2014* 36Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 37Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by PharmaKing Co., Ltd., 2014* 38Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 39Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by TCM Biotech International Corp, 2014* 40Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 41Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Phenex Pharmaceuticals AG, 2014* 42Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014* 43Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Genextra S.p.a., 2014* 44Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 45Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2014* 46Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Third Military Medical University, 2014* 47Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2014* 48Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 49Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 50Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014* 51Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2014* 52Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2014* 53Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bambino Gesu Hospital and Research Institute, 2014* 54
List of FiguresFatty Liver Disease Therapeutics, Global, Clinical Trials by Region (%), 2014* 7Fatty Liver Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8Fatty Liver Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9Fatty Liver Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10Fatty Liver Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11Fatty Liver Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12Fatty Liver Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13Fatty Liver Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2014* 15Fatty Liver Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16Fatty Liver Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2014* 18Fatty Liver Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19Fatty Liver Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20Fatty Liver Disease Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21Fatty Liver Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22Fatty Liver Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23Fatty Liver Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24Fatty Liver Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27Fatty Liver Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28Fatty Liver Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29Fatty Liver Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30Fatty Liver Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32GlobalData Methodology 83
Read the full report:Fatty Liver Disease Global Clinical Trials Review, H2, 2014 https://www.reportbuyer.com/product/617103/Fatty-Liver-Disease-Global-Clinical-Trials-Review-H2-2014.html
For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
SOURCE ReportBuyer
Advertisement
Fatty Liver Disease Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/617103/Fatty-Liver-Disease-Global-Clinical-Trials-Review-H2-2014.html
Advertisement
Fatty Liver Disease Global Clinical Trials Review, H2, 2014
SummaryGlobalData's clinical trial report, "Fatty Liver Disease Global Clinical Trials Review, H2, 2014" provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fatty Liver Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesTable of ContentsTable of Contents 2List of Tables 4List of Figures 5Introduction 6Fatty Liver Disease 6Report Guidance 6Clinical Trials by Region 7Clinical Trials and Average Enrollment by Country 8Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10Top Five Countries Contributing to Clinical Trials in Europe 11Top Countries Contributing to Clinical Trials in North America 12Top Countries Contributing to Clinical Trials in Middle East and Africa 13Top Countries Contributing to Clinical Trials in Central and South America 14Clinical Trials by G7 Countries: Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials 15Clinical Trials by Phase in G7 Countries 16Clinical Trials in G7 Countries by Trial Status 17Clinical Trials by E7 Countries: Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials 18Clinical Trials by Phase in E7 Countries 19Clinical Trials in E7 Countries by Trial Status 20Clinical Trials by Phase 21In Progress Trials by Phase 22Clinical Trials by Trial Status 23Clinical Trials by End Point Status 24Unaccomplished Trials of Fatty Liver Disease 25Subjects Recruited Over a Period of Time 27Clinical Trials by Sponsor Type 28Prominent Sponsors 29Top Companies Participating in Fatty Liver Disease Therapeutics Clinical Trials 30Prominent Drugs 32Latest Clinical Trials News on Fatty Liver Disease 33Jul 30, 2014: Galectin Therapeutics Issues Statement on GR-MD-02 Development Program 33Jul 25, 2014: Galectin Therapeutics to Host Webcast to Discuss Findings From Cohort 2 of Phase 1 Clinical Trial of GR-MD-02 in Fatty Liver Disease With Advanced Fibrosis 34Clinical Trial Profiles 35Clinical Trial Overview of Top Companies 35Merck & Co., Inc. 35Clinical Trial Overview of Merck & Co., Inc. 35Galmed International Ltd. 36Clinical Trial Overview of Galmed International Ltd. 36F. Hoffmann-La Roche Ltd. 37Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 37PharmaKing Co., Ltd. 38Clinical Trial Overview of PharmaKing Co., Ltd. 38Abbott Laboratories 39Clinical Trial Overview of Abbott Laboratories 39TCM Biotech International Corp 40Clinical Trial Overview of TCM Biotech International Corp 40Sanofi 41Clinical Trial Overview of Sanofi 41Phenex Pharmaceuticals AG 42Clinical Trial Overview of Phenex Pharmaceuticals AG 42GW Pharmaceuticals plc 43Clinical Trial Overview of GW Pharmaceuticals plc 43Genextra S.p.a. 44Clinical Trial Overview of Genextra S.p.a. 44Clinical Trial Overview of Top Institutes / Government 45The National Institute of Diabetes and Digestive and Kidney Diseases 45Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 45Tabriz University of Medical Sciences 46Clinical Trial Overview of Tabriz University of Medical Sciences 46Third Military Medical University 47Clinical Trial Overview of Third Military Medical University 47University of Michigan 48Clinical Trial Overview of University of Michigan 48Tehran University of Medical Sciences 49Clinical Trial Overview of Tehran University of Medical Sciences 49Washington University School of Medicine 50Clinical Trial Overview of Washington University School of Medicine 50University of California, San Diego 51Clinical Trial Overview of University of California, San Diego 51FUDAN University 52Clinical Trial Overview of FUDAN University 52Ahvaz Jundishapur University of Medical Sciences 53Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 53Bambino Gesu Hospital and Research Institute 54Clinical Trial Overview of Bambino Gesu Hospital and Research Institute 54Five Key Clinical Profiles 55Appendix 82Abbreviations 82Definitions 82Research Methodology 83Secondary Research 84About GlobalData 84Contact Us 84Disclaimer 84Source 85
List of TablesFatty Liver Disease Therapeutics, Global, Clinical Trials by Region, 2014* 7Fatty Liver Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8Fatty Liver Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9Fatty Liver Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10Fatty Liver Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11Fatty Liver Disease Therapeutics Clinical Trials, North America, Top Countries, 2014* 12Fatty Liver Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13Fatty Liver Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2014* 15Fatty Liver Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16Fatty Liver Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2014* 18Fatty Liver Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19Fatty Liver Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20Fatty Liver Disease Therapeutics, Global, Clinical Trials by Phase, 2014* 21Fatty Liver Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22Fatty Liver Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23Fatty Liver Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24Fatty Liver Disease Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25Fatty Liver Disease Therapeutics, Global, Terminated Clinical Trials, 2014* 26Fatty Liver Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27Fatty Liver Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28Fatty Liver Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29Fatty Liver Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31Fatty Liver Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 35Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Galmed International Ltd., 2014* 36Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 37Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by PharmaKing Co., Ltd., 2014* 38Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 39Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by TCM Biotech International Corp, 2014* 40Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 41Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Phenex Pharmaceuticals AG, 2014* 42Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014* 43Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Genextra S.p.a., 2014* 44Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 45Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2014* 46Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Third Military Medical University, 2014* 47Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2014* 48Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 49Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 50Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014* 51Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2014* 52Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2014* 53Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bambino Gesu Hospital and Research Institute, 2014* 54
List of FiguresFatty Liver Disease Therapeutics, Global, Clinical Trials by Region (%), 2014* 7Fatty Liver Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8Fatty Liver Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9Fatty Liver Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10Fatty Liver Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11Fatty Liver Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12Fatty Liver Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13Fatty Liver Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2014* 15Fatty Liver Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16Fatty Liver Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2014* 18Fatty Liver Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19Fatty Liver Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20Fatty Liver Disease Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21Fatty Liver Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22Fatty Liver Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23Fatty Liver Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24Fatty Liver Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27Fatty Liver Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28Fatty Liver Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29Fatty Liver Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30Fatty Liver Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32GlobalData Methodology 83
Read the full report:Fatty Liver Disease Global Clinical Trials Review, H2, 2014 https://www.reportbuyer.com/product/617103/Fatty-Liver-Disease-Global-Clinical-Trials-Review-H2-2014.html
For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
SOURCE ReportBuyer
